본문 바로가기
KERD
논문KCI 등재

Effective Inhibition of Cancer Cell Growth by a Novel Tripartite Transfection Complex Containing Ribbon Antisense Molecules to hTR

Jong-Gu Park
대한암학회 (Korean Cancer Association)|2004.10|Cancer Research and Treatment|제36권 제5호|pp. 308-314

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류의학일반

초록

Abstract

Purpose: In the present study, ribbon antisense to the hTR RNA, a component of the telomerase complex, was employed to inhibit telomerase activity and cancer cell growth. Materials and Methods: Ribbon antisense molecules to the human hTR gene (hTR-RiAS) were constructed and complexed with a short modified peptide and cationic liposomes to improve the cellular uptake of the antisense molecules. The DPL complexes containing hTR-RiAS were transfected into target cancer cells. Various assays were performed to confirm the effects of the hTR-RiAS on the gene expression and cell proliferation. Results: When cancer cells were treated with hTR-RiAS, the cellular level of hTR mRNA was reduced by more than 95%, as shown by RT-PCR. Further, the telomerase activity was also affected by the antisense treatment. In contrast, both mismatched and scrambled oligonucleotides failed to reduce the levels of hTR mRNA and telomerase activity. When checked for cancer cell viability, hTR- RiAS inhibited cell growth by more than 70%, in a very rapid manner. The reduced cell viability was found to be due to apoptosis of cancer cells. Conclusion: These results show that hTR-RiAS is a powerful anticancer reagent, with the potential for broad efficacy to diverse malignant tumors. (Cancer Res Treat. 2004;36:308-314)

참고문헌 (25)

  1. "Structure and function of telomeres", 350, pp.569~573 (1991)
  2. "Telomeres shorten duringageing of human fibroblasts", 345, pp.458~460 (1990)
  3. "Telomere length predicts replicative capacity ofhuman fibroblasts", 89, pp.10114~10118 (1992)
  4. "Role of telomerase in cellsenescence and oncogenesis", 51, pp.65~79 (2000)
  5. "Anti-apoptoticrole of telomerase in pheochromocytoma cells", 274, pp.7264~7271 (1999)
  6. "Telomere maintenance is dependenton activities required for end repair of double strandbreaks", 8, pp.657~660 (1998)
  7. "Telomeraseenzyme activity and RNA expression in adriamycinresistanthuman breast carcinoma MCF-7 cells", 141, pp.187~194 (1999)
  8. "Specific association of human telomerase activity with immortalcells and cancer", 266, pp.2011~2015 (1994)
  9. "The RNAcomponent of human telomerase", 269, pp.1236~1241 (1995)
  10. "hEST2, the putativehuman telomerase catalytic subunit gene, is up-regulated intumor cells and during immortalization", 90, pp.785~795 (1997)
  11. "Telomerase catalyticsubunit homologs from fission yeast and human", 277, pp.955~959 (1997)
  12. "A mammalian telomerase- associatedprotein", 275, pp.973~977 (1997)
  13. "TLP1:a gene encoding a protein component of mammaliantelomerase is a novel member of WD repeats family", 88, pp.875~884 (1997)
  14. "2-5A antisense telomerase RNA therapy for intracranialmalignant gliomas", 60, pp.4461~4467 (2000)
  15. "Inhibition of human telomerase in immortalhuman cells leads to progressive telomere shortening and celldeath", 96, pp.14276~14281 (1999)
  16. "Inhibitionof telomerase activity of melanoma cells in vitro by antisenseoligonucleotides", 248, pp.368~371 (1998)
  17. "Inhibition of human telomerase activity by peptide nucleicacids", 14, pp.615~619 (1996)
  18. "Effect of antisense human telomerase RNA transfection onthe growth of human gastric cancer cell lines", 255, pp.753~758 (1999)
  19. "Antisense telomerase treatment: inductionof two distinct pathways, apoptosis and differentiation", 12, pp.801~811 (1998)
  20. "Target site search and effective inhibition of leukaemiccell growth by a covalently closed multiple anti-sense oligo-nucleotide to c-myb", 346, pp.295~303 (2000)
  21. "Potent growth inhibition of leukemic cells by novelribbon-type antisense oligonucleotides to c-myb1", 275, pp.4647~4653 (2000)
  22. "Targetedtherapy of human malignant glioma in mouse model by 2-5Aantisense directed against telomerase RNA", 16, pp.3323~3330 (1998)
  23. "Hammerhead ribozyme-mediatedinhibition of telomerase activity in extracts of human hepatocellular carcinoma cells", 225, pp.570~576 (1996)
  24. "Inhibitionof telomerase activity in human cancer cells by RNAinterference", 2, pp.209~216 (2003)
  25. "Treatment of prostatecancer in vitro and in vivo with 2-5A-anti-telomerase RNAcomponent", 19, pp.2205~2211 (2000)

관련 논문AI추천

Changes of Telomerase Activity and Proliferation by Inhibition of Reverse Transcriptase Activity in Human Cancer CellHyun-Cheol Chung, Hyun-Jung Ji, Jae-Kyoung Roh, Jun-Myung Kim, Jun-Suk Kim, Kyu-Hyun Park, Nae-Choon Yoo, Sun-Young Rha, Tae-Soo Kim, Woo-Ick Jang대한암학회 · Cancer Research and Treatment2002 · 제34권 제3호Cholesterol conjugated spermine as a delivery modality of antisense oligonucleotide유훈, 김명수, 임윤경대한구강생물학회 · International Journal of Oral Biology2013 · 제38권 제4호Inhibition of Cervical Cancer Cell Growth by Gene Silencing of HPV16 E6 Induced by Short-interfering RNA김윤식, 박상묵대한임상검사과학회 · 대한임상검사과학회지2011 · 제43권 제3호Therapeutic aptamers: developmental potential as anticancer drugs허균, 김현정, 이지원생화학분자생물학회 · BMB Reports2015 · 제48권 제4호RNA therapy: rich history, various applications and unlimited future prospects김영국생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 Telomerase Activity and Expression of hTR and TERT in Human Soft Tissue SarcomasByung Kee Kim, Jinyoung Yoo, Seok Jin Kang대한암학회 · Cancer Research and Treatment2002 · 제34권 제1호

이 간행물의 다른 논문 (9건)

Transcription Factors in the Cellular Signaling Network as Prime Targets of Chemopreventive PhytochemicalsYoung-Joon Surhpp. 275-286A Phase II Trial of Docetaxel and Ifosfamide for Patients with Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage SettingSeok-Hyun Kim, Young-Sil Hwang, Hea Yong Lee, Joung-Soon Jang, Jong-Duk Lee, Won-Sup Lee, Ho-Cheol Kim, Jung-Hun Kang, 이종석, Gyeong-Won Leepp. 287-292A Phase II Study of Weekly Paclitaxel, Cisplatin and Concurrent Radiation Therapy for Locally-Advanced Unresectable Non-Small Cell Lung Cancer: Early Closure due to Lack of Efficacy경선영, 이재웅, 조은경, 임영희, 정성환, 이규찬, 방수미, 이재훈, 안창혁, 김미경, 신동복, 박정웅, 박세훈pp. 293-297Prognostic Significance of CD24 Expression in Gastric Carcinoma김우호, Nevine S. Darwish, Yong Il Kim, 이병란, 김민아, 장미수, 이혜승pp. 298-302Expression of Caspase-3 and c-myc in Non-Small Cell Lung Cancer김훈교, 조덕곤, 안명임, 조규도, 김치홍, 김수지, 강석진, 조민섭, 조홍주, 정윤주, 송소향, 심병용, 유진영pp. 303-307
원문 보기